As part of last year’s hhc activity, team members at our Exton, Pennsylvania, campus worked with the advocacy organization Unite for HER to better understand this patient community…this patient population is important for Exton team members to listen to and learn from. In addition to having a sophisticated biologics production facility, the Exton campus is also home to the epochal precision anti-cancer theraputics (EPAT) discovery center used to develop precision oncology therapies. Joining forces provided a unique opportunity for Eisai employees to interact with breast and ovarian cancer survivors and to listen, learn and ideate.
Joye Bramble PhD
Exton Site Head and Vice President Biopharmaceutical Development at Eisai Inc. (Read Joye’s blog to learn more)